Early postmenopausal women who were not on hormone replacement therapy completed a REDCap survey on demographics and risk factor, Berlin questionnaire and Mail-in Cognitive Function Screening Instrument (MCFSI) score to assess cognitive impairment. Early postmenopausal women at high risk for OSAS reported more cognitive impairment than those at low risk for OSAS.
This review discusses the pathophysiology, consequences, screening and diagnosis of Obesity Hypoventilation Syndrome (OHS). An overview of the treatment options for the management of OHS is included.
This review discusses the pathological commonalities between OSA and Alzheimer’s Disease. The potential prevention of cognitive decline in middle-aged and elderly persons with treatment of OSA is reviewed.
In this study, the authors examined the prevalence of chronic widespread musculoskeletal pain (CWP) in patients who were undergoing PSG for suspected OSAS. They found that 41 of the 74 patients (55%) had CWP. Female patients had a greater risk of CWP than male patients. Female OSAS patients with CWP had higher pain levels, greater disability levels, higher BMIs and a lower quality of life.
This review suggests that there is “no significant difference in the postoperative adverse events between CPAP and no-CPAP treatment. Patients using CPAP had significantly lower postoperative AHI and a trend toward shorter LOS. There may be potential benefits in the use of CPAP during the perioperative period”